Meissner Wassilios - Publications

Affiliations: 
CHU Bordeaux, Pessac, Nouvelle-Aquitaine, France 

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N'Guyen K, Péréon Y, Fabre N, Robin E, Courtois S, Guyant-Maréchal L, Zagnoli F, Rudolf G, Renaud M, Sévin-Allouet M, et al. Delayed-onset Friedreich's ataxia revisited. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26388117 DOI: 10.1002/mds.26382  0.84
2015 Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG. Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia. Parkinsonism & Related Disorders. 21: 1273-7. PMID 26305998 DOI: 10.1016/j.parkreldis.2015.08.013  0.48
2015 Bassil F, Monvoisin A, Canron MH, Vital A, Meissner WG, Tison F, Fernagut PO. Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26260627 DOI: 10.1002/Mds.26329  0.48
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002  0.48
2015 Dehay B, Bourdenx M, Gorry P, Przedborski S, Vila M, Hunot S, Singleton A, Olanow CW, Merchant KM, Bezard E, Petsko GA, Meissner WG. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. The Lancet. Neurology. PMID 26050140 DOI: 10.1016/S1474-4422(15)00006-X  0.52
2015 Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG. Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative. Neurobiology of Disease. 80: 29-41. PMID 25982836 DOI: 10.1016/J.Nbd.2015.05.004  0.48
2015 Rascol O, Perez-Lloret S, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Negre-Pages L. Falls in ambulatory non-demented patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25845678 DOI: 10.1007/s00702-015-1396-2  0.48
2015 Aupy J, Vital A, Rougier MB, Gradel A, Meissner W, Marchal C, Penchet G, Brochet B. Presumed tuberculous retrobulbar optic neuritis: a diagnosis challenge. Journal of Neurology. 262: 481-4. PMID 25536904 DOI: 10.1007/s00415-014-7611-5  0.84
2015 Renaud M, Perriard J, Coudray S, Sévin-Allouet M, Marcel C, Meissner WG, Chanson JB, Collongues N, Philippi N, Gebus O, Quenardelle V, Castrioto A, Krack P, N'Guyen K, Lefebvre F, et al. Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice. Journal of Neurology. 262: 435-42. PMID 25451852 DOI: 10.1007/s00415-014-7557-7  0.48
2014 Adamchic I, Hauptmann C, Barnikol UB, Pawelczyk N, Popovych O, Barnikol TT, Silchenko A, Volkmann J, Deuschl G, Meissner WG, Maarouf M, Sturm V, Freund HJ, Tass PA. Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1679-84. PMID 24976001 DOI: 10.1002/Mds.25923  0.48
2014 Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Schelosky L, Tison F, Rascol O. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. Jama Neurology. 71: 884-90. PMID 24839938 DOI: 10.1001/jamaneurol.2014.753  0.48
2014 Ghorayeb I, Dupouy S, Tison F, Meissner WG. Restless legs syndrome in multiple system atrophy. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 1523-7. PMID 24818598 DOI: 10.1007/s00702-014-1232-0  0.48
2014 Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 857-67. PMID 24753321 DOI: 10.1002/Mds.25880  0.48
2014 Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG. Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies. Neurobiology of Disease. 67: 133-9. PMID 24727096 DOI: 10.1016/J.Nbd.2014.03.021  0.52
2014 Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, Rascol O. A cross-sectional study on drug use in multiple system atrophy. Cns Drugs. 28: 483-90. PMID 24683045 DOI: 10.1007/s40263-014-0159-1  0.48
2014 Meissner WG, Flabeau O, Perez P, Taillard J, Marquant F, Dupouy S, Tison F, Philip P, Ghorayeb I. Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy. Sleep Medicine. 15: 476-9. PMID 24656908 DOI: 10.1016/j.sleep.2013.12.013  0.48
2014 Bassil F, Fernagut PO, Bezard E, Meissner WG. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? Progress in Neurobiology. 118: 1-18. PMID 24582776 DOI: 10.1016/J.Pneurobio.2014.02.005  0.52
2014 Badat Y, Meissner WG, Laharie D. Demyelination in a patient receiving ustekinumab for refractory Crohn's disease. Journal of Crohn's & Colitis. 8: 1138-9. PMID 24572561 DOI: 10.1016/j.crohns.2014.02.004  0.48
2014 Flabeau O, Meissner WG, Ozier A, Berger P, Tison F, Fernagut PO. Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 388-95. PMID 24442757 DOI: 10.1002/Mds.25804  0.48
2014 Porras G, De Deurwaerdere P, Li Q, Marti M, Morgenstern R, Sohr R, Bezard E, Morari M, Meissner WG. L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum. Scientific Reports. 4: 3730. PMID 24429495 DOI: 10.1038/Srep03730  0.52
2014 Tison F, Meissner WG. Movement disorders in 2013: diagnosing and treating PD-the earlier the better? Nature Reviews. Neurology. 10: 65-6. PMID 24394288 DOI: 10.1038/nrneurol.2013.273  0.48
2014 Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, et al. Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. Neurology. 82: 300-7. PMID 24371304 DOI: 10.1212/Wnl.0000000000000050  0.84
2014 Auzou N, Foubert-Samier A, Dupouy S, Meissner WG. Facial emotion recognition is inversely correlated with tremor severity in essential tremor. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 347-51. PMID 24178244 DOI: 10.1007/s00702-013-1110-1  0.48
2013 Mazere J, Meissner WG, Sibon I, Lamare F, Tison F, Allard M, Mayo W. [(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6). Neuroimage. Clinical. 3: 212-7. PMID 24179865 DOI: 10.1016/J.Nicl.2013.07.012  0.48
2013 Lamare F, Mazere J, Attila M, Mayo W, De Clermont-Gallerande H, Meissner W, Fernandez P, Allard M. Improvement of in vivo quantification of [123I]-Iodobenzovesamicol in single-photon emission computed tomography/computed tomography using anatomic image to brain atlas nonrigid registration. Molecular Imaging. 12: 288-99. PMID 23759370 DOI: 10.2310/7290.2012.00043  0.84
2013 Meissner WG, Fernet M, Couturier J, Hall J, Laugé A, Henry P, Stoppa-Lyonnet D, Tison F. Isolated generalized dystonia in biallelic missense mutations of the ATM gene. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1897-9. PMID 23640770 DOI: 10.1002/mds.25487  0.48
2013 Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, et al. The natural history of multiple system atrophy: a prospective European cohort study. The Lancet. Neurology. 12: 264-74. PMID 23391524 DOI: 10.1016/S1474-4422(12)70327-7  0.48
2013 Tison F, Nègre-Pagès L, Meissner WG, Dupouy S, Li Q, Thiolat ML, Thiollier T, Galitzky M, Ory-Magne F, Milhet A, Marquine L, Spampinato U, Rascol O, Bezard E. Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. Parkinsonism & Related Disorders. 19: 416-21. PMID 23283428 DOI: 10.1016/j.parkreldis.2012.12.003  0.52
2012 Tass PA, Qin L, Hauptmann C, Dovero S, Bezard E, Boraud T, Meissner WG. Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Annals of Neurology. 72: 816-20. PMID 23280797 DOI: 10.1002/ana.23663  0.52
2012 Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roué-Jagot C, Sedel F, Charles P, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 79: 1898-907. PMID 23077007 DOI: 10.1212/Wnl.0B013E318271F7Ff  0.48
2012 Meissner WG, Foubert-Samier A, Dupouy S, Gerdelat-Mas A, Debs R, Marquant F, De Cock VC, Rascol O, Tison F, Pavy-Le Traon A. Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1574-7. PMID 23033055 DOI: 10.1002/mds.25174  0.48
2012 Mazère J, Meissner WG, Mayo W, Sibon I, Lamare F, Guilloteau D, Tison F, Allard M. Progressive supranuclear palsy: in vivo SPECT imaging of presynaptic vesicular acetylcholine transporter with [123I]-iodobenzovesamicol. Radiology. 265: 537-43. PMID 23012462 DOI: 10.1148/Radiol.12112650  0.48
2012 Meissner WG. Methods for treating neurological conditions (WO2011159945). Expert Opinion On Therapeutic Patents. 22: 847-52. PMID 22697132 DOI: 10.1517/13543776.2012.699524  0.48
2012 Damon-Perrière N, Foubert-Samier A, De Cock VC, Gerdelat-Mas A, Debs R, Pavy-Le Traon A, Senard JM, Rascol O, Tison F, Meissner WG. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism & Related Disorders. 18: 612-5. PMID 22236582 DOI: 10.1016/j.parkreldis.2011.12.009  0.48
2012 Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG. Ambiguous mechanisms of dysphagia in multiple system atrophy. Brain : a Journal of Neurology. 135: e205; author reply e. PMID 21824966 DOI: 10.1093/Brain/Awr185  0.48
2011 Tass PA, Qin L, Hauptmann C, Dovero S, Bezard E, Boraud T, Meissner WG. The translational value of the MPTP non-human primate model of Parkinsonism for deep brain stimulation research. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2011: 663-6. PMID 22254396 DOI: 10.1109/IEMBS.2011.6090148  0.52
2011 Paulat R, Meissner W, Morgenstern R, Kupsch A, Harnack D. Development of an implantable microstimulation system for chronic DBS in rodents. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2011: 660-2. PMID 22254395 DOI: 10.1109/IEMBS.2011.6090147  0.84
2011 Prashanth LK, Fox S, Meissner WG. l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment. International Review of Neurobiology. 98: 31-54. PMID 21907082 DOI: 10.1016/B978-0-12-381328-2.00002-X  0.48
2011 Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E. Priorities in Parkinson's disease research. Nature Reviews. Drug Discovery. 10: 377-93. PMID 21532567 DOI: 10.1038/Nrd3430  0.52
2011 Reese R, Leblois A, Steigerwald F, Pötter-Nerger M, Herzog J, Mehdorn HM, Deuschl G, Meissner WG, Volkmann J. Subthalamic deep brain stimulation increases pallidal firing rate and regularity. Experimental Neurology. 229: 517-21. PMID 21303674 DOI: 10.1016/J.Expneurol.2011.01.020  0.48
2010 Meissner WG, Vital A, Ghorayeb I, Guehl D, Tison F. Dyspnea as first sign of autonomic failure in postmortem confirmed multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1997-8. PMID 20669251 DOI: 10.1002/Mds.23182  0.48
2010 Leblois A, Reese R, Labarre D, Hamann M, Richter A, Boraud T, Meissner WG. Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster. Neurobiology of Disease. 38: 288-98. PMID 20138992 DOI: 10.1016/J.Nbd.2010.01.020  0.84
2009 Foubert-Samier A, Kazadi A, Rouanet M, Vital A, Lagueny A, Tison F, Meissner W. Axonal sensory motor neuropathy in copper-deficient Wilson's disease. Muscle & Nerve. 40: 294-6. PMID 19609919 DOI: 10.1002/mus.21425  0.84
2009 Reese R, Charron G, Nadjar A, Aubert I, Thiolat ML, Hamann M, Richter A, Bezard E, Meissner WG. High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster. Neurobiology of Disease. 35: 399-405. PMID 19501651 DOI: 10.1016/j.nbd.2009.05.022  0.52
2008 Reese R, Winter C, Nadjar A, Harnack D, Morgenstern R, Kupsch A, Bezard E, Meissner W. Subthalamic stimulation increases striatal tyrosine hydroxylase phosphorylation. Neuroreport. 19: 179-82. PMID 18185104 DOI: 10.1097/Wnr.0B013E3282F417B4  0.84
2008 Harnack D, Meissner W, Jira JA, Winter C, Morgenstern R, Kupsch A. Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism. Experimental Neurology. 210: 257-60. PMID 18036524 DOI: 10.1016/J.Expneurol.2007.10.002  0.84
2008 Winter C, Lemke C, Sohr R, Meissner W, Harnack D, Juckel G, Morgenstern R, Kupsch A. High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat. Experimental Brain Research. 185: 497-507. PMID 17962928 DOI: 10.1007/S00221-007-1171-1  0.84
2008 Harnack D, Meissner W, Paulat R, Hilgenfeld H, Müller WD, Winter C, Morgenstern R, Kupsch A. Continuous high-frequency stimulation in freely moving rats: development of an implantable microstimulation system. Journal of Neuroscience Methods. 167: 278-91. PMID 17942159 DOI: 10.1016/J.Jneumeth.2007.08.019  0.84
2007 Leblois A, Meissner W, Bioulac B, Gross CE, Hansel D, Boraud T. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. The European Journal of Neuroscience. 26: 1701-13. PMID 17880401 DOI: 10.1111/J.1460-9568.2007.05777.X  0.84
2007 Meissner W, Guigoni C, Cirilli L, Garret M, Bioulac BH, Gross CE, Bezard E, Benazzouz A. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease. The European Journal of Neuroscience. 25: 1492-500. PMID 17425575 DOI: 10.1111/J.1460-9568.2007.05406.X  0.84
2006 Leblois A, Meissner W, Bezard E, Bioulac B, Gross CE, Boraud T. Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys. The European Journal of Neuroscience. 24: 1201-8. PMID 16930445 DOI: 10.1111/J.1460-9568.2006.04984.X  0.84
2006 Winter C, Hosmann K, Harnack D, Meissner W, Paul G, Morgenstern R, Kupsch A. Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease. Synapse (New York, N.Y.). 60: 69-80. PMID 16598703 DOI: 10.1002/Syn.20269  0.84
2006 Leblois A, Boraud T, Meissner W, Bergman H, Hansel D. Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 3567-83. PMID 16571765 DOI: 10.1523/Jneurosci.5050-05.2006  0.84
2006 Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiology of Disease. 22: 586-98. PMID 16531050 DOI: 10.1016/j.nbd.2006.01.009  0.84
2006 Meissner W, Leblois A, Benazzouz A, Boraud T. Reply to: Deep brain stimulation in Parkinson's disease can mimic the 300 Hz subthalamic rhythm Subthalamic high-frequency stimulation drives subthalamic oscillatory activity at stimulation frequency while firing rate is reduced [5] Brain. 129: e60. DOI: 10.1093/Brain/Awl210  0.44
2005 Meissner W, Leblois A, Hansel D, Bioulac B, Gross CE, Benazzouz A, Boraud T. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain : a Journal of Neurology. 128: 2372-82. PMID 16123144 DOI: 10.1093/Brain/Awh616  0.84
2005 Sharott A, Magill PJ, Harnack D, Kupsch A, Meissner W, Brown P. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. The European Journal of Neuroscience. 21: 1413-22. PMID 15813951 DOI: 10.1111/J.1460-9568.2005.03973.X  0.84
2005 Meissner W, Schreiter D, Volkmann J, Trottenberg T, Schneider GH, Sturm V, Deuschl G, Kupsch A. Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany. Journal of Neurology. 252: 218-23. PMID 15729530 DOI: 10.1007/S00415-005-0640-3  0.84
2004 Pioli E, Sohr R, Meissner W, Barthe N, Gross CE, Bezard E, Bioulac BH. Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex. Neurochemistry International. 45: 995-1004. PMID 15337298 DOI: 10.1016/j.neuint.2004.06.003  0.84
2004 Harnack D, Winter C, Meissner W, Reum T, Kupsch A, Morgenstern R. The effects of electrode material, charge density and stimulation duration on the safety of high-frequency stimulation of the subthalamic nucleus in rats. Journal of Neuroscience Methods. 138: 207-16. PMID 15325129 DOI: 10.1016/J.Jneumeth.2004.04.019  0.84
2004 Meissner W, Gross CE, Harnack D, Bioulac B, Benazzouz A. Deep brain stimulation for Parkinson's disease: Potential risk of tissue damage associated with external stimulation--erratum. Annals of Neurology. 56: 309-10. PMID 15293291 DOI: 10.1002/ana.20191  0.84
2004 Harnack D, Hamann M, Meissner W, Morgenstern R, Kupsch A, Richter A. High-frequency stimulation of the entopeduncular nucleus improves dystonia in dtsz hamsters. Neuroreport. 15: 1391-3. PMID 15194859  0.84
2004 Meissner W, Hill MP, Tison F, Gross CE, Bezard E. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends in Pharmacological Sciences. 25: 249-53. PMID 15120490 DOI: 10.1016/j.tips.2004.03.003  0.84
2004 Bergmann O, Winter C, Meissner W, Harnack D, Kupsch A, Morgenstern R, Reum T. Subthalamic high frequency stimulation induced rotations are differentially mediated by D1 and D2 receptors. Neuropharmacology. 46: 974-83. PMID 15081794 DOI: 10.1016/j.neuropharm.2004.01.007  0.84
2004 Meissner W, Gross CE, Harnack D, Bioulac B, Benazzouz A. Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation. Annals of Neurology. 55: 449-50. PMID 14991830 DOI: 10.1002/ana.20002  0.84
2004 Paul G, Meissner W, Rein S, Harnack D, Winter C, Hosmann K, Morgenstern R, Kupsch A. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Experimental Neurology. 185: 272-80. PMID 14736508 DOI: 10.1016/S0014-4886(03)00363-7  0.84
2004 Benazzouz A, Tai CH, Meissner W, Bioulac B, Bezard E, Gross C. High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 528-30. PMID 14715698 DOI: 10.1096/fj.03-0576fje  0.84
2004 Meissner W, Harnack D, Hoessle N, Bezard E, Winter C, Morgenstern R, Kupsch A. High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission. Neurochemistry International. 44: 281-6. PMID 14602091 DOI: 10.1016/S0197-0186(03)00138-4  0.84
2003 Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, Bezard E. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. Molecular Neurobiology. 28: 209-18. PMID 14709785 DOI: 10.1385/Mn:28:3:209  0.84
2003 Kupsch A, Kuehn A, Klaffke S, Meissner W, Harnack D, Winter C, Haelbig TD, Kivi A, Arnold G, Einhäupl KM, Schneider GH, Trottenberg T. Deep brain stimulation in dystonia. Journal of Neurology. 250: I47-52. PMID 12761637 DOI: 10.1007/S00415-003-1110-2  0.84
2003 Meissner W, Dovero S, Bioulac B, Gross CE, Bezard E. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiology of Disease. 13: 46-54. PMID 12758066 DOI: 10.1016/S0969-9961(03)00011-1  0.84
2003 Meissner W, Harnack D, Reese R, Paul G, Reum T, Ansorge M, Kusserow H, Winter C, Morgenstern R, Kupsch A. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. Journal of Neurochemistry. 85: 601-9. PMID 12694386 DOI: 10.1046/j.1471-4159.2003.01665.x  0.84
2003 Pioli EY, Gross CE, Meissner W, Bioulac BH, Bezard E. The deafferented nonhuman primate is not a reliable model of intractable pain. Neurological Research. 25: 127-9. PMID 12635510 DOI: 10.1179/016164103101201274  0.84
2002 Brown P, Kupsch A, Magill PJ, Sharott A, Harnack D, Meissner W. Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat. Experimental Neurology. 177: 581-5. PMID 12429204 DOI: 10.1006/Exnr.2002.7984  0.84
Show low-probability matches.